echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Neuron Jiang Youxing's group reveals the working mechanism of CNGA1/B1 ion channels in human rod cells

    Neuron Jiang Youxing's group reveals the working mechanism of CNGA1/B1 ion channels in human rod cells

    • Last Update: 2021-11-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    Responsible Editor | Xi The mammalian cyclic nucleotide-gated channels (CNG channels) play an important role in the signal transduction process of the visual and olfactory sensory systems


    After light changes and odor molecules are recognized by receptors on the cell membrane of cones/rods and olfactory sensory neurons, the levels of cyclic nucleotides in the cells change, which then regulate the opening or closing of CNG channels [1]

    After binding to cyclic nucleotides (cGMP or cAMP) in the cytoplasm, the CNG channel undergoes a conformational change, thereby opening the ion conduction pathway [2]

    In mammals, the CNG ion channel family contains 6 homologous components: 4 A subunits (A1–A4) and 2 B subunits (B1, B3)

    Among them, the A1, A2, and A3 subunits can each form a functional homotetramer, which is often used to study the physiological characteristics of CNG channels

    However, the natural CNG ion channel is a heterotetramer composed of A and B subunits [3]

    Although CNGB subunits alone cannot form functional ion channels, they endow CNG ion channels with unique functional characteristics in their natural state

    The natural ion channels CNGA1/B1 in rod cells have different physiological characteristics from the homotetramer CNGA1

    CNGA1/B1 has a weaker calcium blocking phenomenon; in addition to being fully activated by cGMP, CNGA1/B1 can also be partially activated by high concentrations of cAMP; L-cis-Diltiazem can effectively block CNGA1/B1, and has a blocking effect on CNGA1 But it is very weak [3,4] (Figure 1)

    Although the structure of human CNGA1 homotetramer has been resolved [5], the molecular mechanism of the lack of structural information of CNGB1 leading to these unique physiological properties is still unclear

     On October 25, 2021, Jiang Youxing's research group from the University of Texas Southwestern Medical Center published an article Structural mechanisms of assembly, permeation, gating, and pharmacology of native human rod CNG channel in Neuron, analyzing human rod cells The three-dimensional structure of CNGA1/B1 ion channels in different states (Apo, cGMP-bound open, cAMP-bound closed and L-cis-Diltiazem-blocked) reveals that CNG ion channels in their natural state have unique ion penetration, gating regulation, The pharmacological characteristics and the structural basis of the 3:1 ratio assembly

    The researchers first co-expressed CNGA1 and CNGB1 subunits in a special way, purified a homogeneously assembled CNGA1:CNGB1 heterotetramer in a ratio of 3:1, and then used cryo-electron microscopy to analyze its three-dimensionality in different states.


    CNGA1/B1 has an overall structure similar to CNGA1 homotetramer

    The unique amino acid residues of B1 in the ion conduction pathway attenuate the calcium blockage and single channel conductance of CNGA1/B1

    Below the CNBD domain of CNGA1/B1, the CLZ domains of three A1 subunits form a 3-helix coiled coil structure, interacting with the α-helix of one B1 subunit, revealing the ratio of A1:B1 to 3:1 The structural basis for assembly (Figure 2A)

    In the CNGA1/B1 heterotetramer in the closed state of Apo, the gated amino acid side chains of A1 and B1 are located in the middle of the pore, blocking the passage of ions; but in the open state of cGMP binding, only two A1 subunits are gated The amino acid side chain flips to the outside of the channel, while the gated amino acid side chains of the other A1 and B1 subunits only move outwards slightly, without flipping, which results in an asymmetric channel opening

    Compared with the symmetrically opened CNGA1 homotetramer, CNGA1/B1 has a narrower ion conduction path (Figure 2B)

     The cGMP-bound samples showed two different open states

    These two states have similar asymmetric open pores, but the CNBD domain of the B1 subunit is in a different conformation

    Compared with the closed state structure, the CNBD domain of the four subunits in CNGA1/B1 undergoes conformational changes after binding to cGMP, but the ability to transmit this change and ultimately cause the change of the ion channel spiral S6 is different, which causes Although all four subunits can bind ligands, only the gates of two A subunits enter the open state (Figure 3)

    The activation efficiency of cAMP on CNGA1/B1 is very low.
    Although the three-dimensional structure of cAMP binding can be resolved, it is in the closed state.
    Therefore, the structural mechanism of cAMP activation is unclear


     In order to reveal the structural basis of the unique pharmacomechanical properties of CNG ion channels in the natural state, the author also analyzed the structure of CNGA1/B1 and L-cis-Diltiazem complex

    L-cis-Diltiazem is combined in the center of the open pore.
    The B1 subunit does not provide any special interaction, but the unique asymmetric gated structure of CNGA1/B1 creates a perfect open space for L-cis-Diltiazem.
    -cis-Diltiazem is stabilized by hydrophobic interactions, which also explains why CNGA1 homotetramer cannot bind to L-cis-Diltiazem


    In general, by analyzing the structure of CNGA1/B1 ion channels in different states, the structural basis of its unique assembly method, ion penetration, gating mechanism and pharmacological properties are revealed

    In the closed state, CNGA1/B1 heterotetramer and CNGA1 homotetramer have similar structures; the combination of cGMP and CNGA1/B1 causes conformational changes, but the four subunits have different ability to transmit conformational changes and cause changes in channel spiral S6 , Resulting in the asymmetric gate opening of CNGA1/B1, and this asymmetric gate is the structural basis of its unique pharmacological properties

    Original link: https:// Reprinting instructions [Non-original article] The copyright of this article belongs to the author of the article.
    Personal forwarding and sharing are welcome.
    Reprinting is prohibited without permission , The author has all legal rights, and offenders must be investigated


     References 1.
    Bradley, J.
    , Reisert, J.
    , and Frings, S.
    Regulation of cyclic nucleotide-gated channels.
    Curr Opin Neurobiol 15, 343-349.
    Varnum, MD, and Zagotta, WN (1996 ).
    Subunit interactions in the activation of cyclic nucleotide-gated ion channels.
    Biophys J 70, 2667-2679.
    Kaupp, UB, and Seifert, R.
    Cyclic nucleotide-gated ion channels.
    Physiol Rev 82, 769-824.
    4 Chen, TY, Peng, YW, Dhallan, RS, Ahamed, B.
    , Reed, RR, and Yau, KW (1993).
    A new subunit of the cyclic nucleotide-gated cation channel in retinal rods.
    Nature 362, 764- 767.
    Haynes, LW (1992).
    Block of the cyclic GMP-gated channel of vertebrate rod and cone photoreceptors by l-cis-diltiazem.
    J Gen Physiol 100, 783-801.
    Xue, J.
    , Han, Y.
    , Zeng , W.
    , Wang, Y.
    , and Jiang, Y.
    Structural mechanisms of gating and selectivity of human rod CNGA1 channel.
    Neuron 109, 1302-1313 e1304.

    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.